CEOs of NVIDIA and Lilly Share ‘Blueprint for What Is Possible’ in AI and Drug Discovery
The co-innovation lab builds on Lilly’s previously announced AI supercomputer — the biopharma industry’s most powerful AI factory , an NVIDIA DGX SuperPOD with DGX B300 systems — which will train large-scale biomedical f…









